Patient-Centered Practice Guidelines : GRADEing Evidence to Incorporate Certainty, Balance Between Benefits and Harms, Equity, Feasibility, and Cost-Effectiveness
Copyright © 2024 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved..
The practice of medicine in recent years has emphasized the use of evidence-based clinical guidelines to help inform treatment decisions. Since its development in 2004, the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach has offered a systematic process for reviewing and summarizing the certainty of evidence found in the medical literature regarding various treatment options. To develop truly patient-centered care guidelines, this appraisal of the certainty of evidence must be combined with an understanding of the balance between benefits and harms, patient preferences, equity, feasibility, cost-effectiveness, and policy implications. This review examines each of these domains in detail, exploring the process and benefits of developing relevant, patient-focused guidelines directly applicable to the practice of modern medicine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
The journal of allergy and clinical immunology. In practice - (2024) vom: 11. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stephen, Ellen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Balance between benefits and harms |
---|
Anmerkungen: |
Date Revised 01.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jaip.2024.03.008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369570588 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369570588 | ||
003 | DE-627 | ||
005 | 20240401232754.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240312s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaip.2024.03.008 |2 doi | |
028 | 5 | 2 | |a pubmed24n1359.xml |
035 | |a (DE-627)NLM369570588 | ||
035 | |a (NLM)38467331 | ||
035 | |a (PII)S2213-2198(24)00269-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stephen, Ellen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patient-Centered Practice Guidelines |b GRADEing Evidence to Incorporate Certainty, Balance Between Benefits and Harms, Equity, Feasibility, and Cost-Effectiveness |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. | ||
520 | |a The practice of medicine in recent years has emphasized the use of evidence-based clinical guidelines to help inform treatment decisions. Since its development in 2004, the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach has offered a systematic process for reviewing and summarizing the certainty of evidence found in the medical literature regarding various treatment options. To develop truly patient-centered care guidelines, this appraisal of the certainty of evidence must be combined with an understanding of the balance between benefits and harms, patient preferences, equity, feasibility, cost-effectiveness, and policy implications. This review examines each of these domains in detail, exploring the process and benefits of developing relevant, patient-focused guidelines directly applicable to the practice of modern medicine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Balance between benefits and harms | |
650 | 4 | |a Cost-effectiveness | |
650 | 4 | |a Equity | |
650 | 4 | |a Evidence certainty | |
650 | 4 | |a Feasibility | |
650 | 4 | |a GRADE | |
700 | 1 | |a Conway, Alexandra E |e verfasserin |4 aut | |
700 | 1 | |a Codispoti, Christopher D |e verfasserin |4 aut | |
700 | 1 | |a Abrams, Elissa |e verfasserin |4 aut | |
700 | 1 | |a Lieberman, Jay A |e verfasserin |4 aut | |
700 | 1 | |a Ledford, Dennis |e verfasserin |4 aut | |
700 | 1 | |a Pongdee, Thanai |e verfasserin |4 aut | |
700 | 1 | |a Shaker, Marcus |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology. In practice |d 2013 |g (2024) vom: 11. März |w (DE-627)NLM227247523 |x 2213-2201 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:11 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaip.2024.03.008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 11 |c 03 |